LUMO - Lumos Pharma - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

LUMO is currently covered by 3 analysts with an average price target of $-3.45. This is a potential upside of $-7.79 (-179.49%) from yesterday's end of day stock price of $4.34.

Lumos Pharma's activity chart (see below) currently has 29 price targets and 36 ratings on display. The stock rating distribution of LUMO is 85.71% BUY and 14.29% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 63.17% with an average time for these price targets to be met of 267.8 days.

Highest price target for LUMO is $13, Lowest price target is $4.25, average price target is $-3.45.

Most recent stock forecast was given by EDWARD WHITE from HCWAINWRIGHT on 08-Nov-2024. First documented stock forecast 10-May-2016.

Currently out of the existing stock ratings of LUMO, 6 are a BUY (85.71%), 1 are a HOLD (14.29%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$4.25

$-0.09 (-2.07%)

$4.25

1 months 10 days ago
(08-Nov-2024)

1/6 (16.67%)

$-0.09 (-2.07%)

148

Buy

$13

$8.66 (199.54%)

4 months 16 days ago
(02-Aug-2024)

0/1 (0%)

$11.13 (595.19%)

Buy

$10

$5.66 (130.41%)

$10

1 years 3 months 26 days ago
(22-Aug-2023)

1/4 (25%)

$7.03 (236.70%)

28

Hold

$7

$2.66 (61.29%)

$7

2 years 10 days ago
(08-Dec-2022)

2/4 (50%)

$2.8 (66.67%)

79

Buy

$26

2 years 1 months 4 days ago
(14-Nov-2022)

2/5 (40%)

$17.95 (222.98%)

182

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is LUMO (Lumos Pharma) average time for price targets to be met?

On average it took 267.8 days on average for the stock forecasts to be realized with a an average price target met ratio 63.17

Which analyst has the current highest performing score on LUMO (Lumos Pharma) with a proven track record?

PETER LAWSON

Which analyst has the most public recommendations on LUMO (Lumos Pharma)?

Peter Lawson works at BARCLAYS and has 15 price targets and 8 ratings on LUMO

Which analyst is the currently most bullish on LUMO (Lumos Pharma)?

Mara Goldstein with highest potential upside - $21.66

Which analyst is the currently most reserved on LUMO (Lumos Pharma)?

Michael Ulz with lowest potential downside - -$0.34

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?